The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
about
Management of relapsed ovarian cancer: a reviewTrial watch - inhibiting PARP enzymes for anticancer therapyNew strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncologyEnhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsTNKS1BP1 functions in DNA double-strand break repair though facilitating DNA-PKcs autophosphorylation dependent on PARP-1Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ationReduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionA Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factorsp21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation.Dual-Modality Optical/PET Imaging of PARP1 in GlioblastomaInduction of Poly(ADP-ribose) Polymerase in Mouse Bone Marrow Stromal Cells Exposed to 900 MHz Radiofrequency Fields: Preliminary Observations.PARP activation promotes nuclear AID accumulation in lymphoma cellsArsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cellsEvaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy.Increasing sensitivity to DNA damage is a potential driver for human ovarian cancerCharacterization of the DNA dependent activation of human ARTD2/PARP2.New directions in poly(ADP-ribose) polymerase biology.PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.Reversing ADP-ribosylation.Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies.Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.Acetylation of 53BP1 dictates the DNA double strand break repair pathway.CREBBP and p300 lysine acetyl transferases in the DNA damage response.Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress.PARP1-dependent recruitment of the FBXL10-RNF68-RNF2 ubiquitin ligase to sites of DNA damage controls H2A.Z loading.PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
P2860
Q26741755-DCBC796C-0F57-4858-895C-2D365F867FA8Q26745673-F594585E-BEB5-4A20-B480-F95CF90B221BQ26745678-6477937C-AF6D-4E05-9E4D-30E9C8ADF106Q26768267-6E805B6A-8B68-449B-AD9C-BA333CD208CDQ28115068-3C66735E-1F41-4A58-8B6E-1F3EC07137CCQ28554210-4AD23F51-2764-4F54-8F15-A861D7211D7DQ29030215-DDA704AF-AB36-47A9-B783-4B70BE1E0F78Q35640249-CAC21DE6-9CD9-4BE8-AEC8-D6E8BF30B209Q35885207-9F0D9A68-2044-462B-BD2D-14773A7F03A3Q35966143-49D86E32-0E14-4D87-9845-977FE07ED813Q36172457-B96CBB42-33D1-41D2-A23D-566A7033EE69Q36845495-E71F542A-CD17-4A99-80DD-094CDA265614Q37022423-FC1DBFB9-AEEE-460C-8CF6-E2F7FCB1EE2FQ37148048-4E36F180-8B24-482F-9BFC-23F89A48859CQ37158437-8EBB57E0-3F73-4547-8FA5-8B5126A5E50AQ37580300-33287E84-BEF2-4547-884B-9BD6EAF34BDEQ38290704-59711A92-EE8F-4B3B-B6D4-05CBDCEF22D1Q38810648-086ECFC1-385F-4380-895F-4669DB86D227Q38844568-42AC5CF1-7297-4EEF-AA7C-CEAEE93FF408Q41276800-2A30BF4A-D2DC-44F5-A584-2252652FFEE7Q41539026-DF094939-F95B-410A-B766-39E730773872Q41572285-9196A0FD-5B99-4CBA-BB16-8E18E6CF3DFAQ42083096-BCE88143-AAB5-48BF-A501-0A43F12700F9Q47104545-ADA7AA64-1E79-48E7-8DA4-5B42CEB6BFCEQ47115127-15898B0C-0634-46BD-AECD-9F935C5443D0Q47347231-1061BDB5-7A10-4AE0-A6FB-1993879E40C7Q47369126-C17C9C8E-F3A3-4F44-A17A-C4939D27420CQ49830073-39E43A4C-02E2-43A6-AAF6-5B323E617CE1Q55615916-BA584E19-B5A2-4C64-92C3-B26C359ABA93Q58786750-C7D68CDA-6DB6-4F21-AFF8-0BAE0319BD90
P2860
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@ast
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@en
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@nl
type
label
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@ast
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@en
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@nl
prefLabel
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@ast
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@en
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@nl
P2860
P921
P3181
P356
P1433
P1476
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
@en
P2860
P2888
P304
P3181
P356
10.1038/ONC.2014.295
P407
P577
2015-06-01T00:00:00Z
P5875
P6179
1049689239